(a) What are the reason(s) that production at the Nuclear Energy Corporation’s facility at Pelindaba has been shut down, (b) on what date did production cease and (c) on what date is it expected to be restored;
(2) (a) what has been the estimated total loss of income since the date of shutdown and (b) what
percentage of the facility’s income is normally generated in foreign currency;
(3) (a) what is the average monthly operating costs for the facility and (b) what will the total additional cost be to bring the facility back into production;
(4) (a) who is to be held accountable for this shutdown and loss of income and (b) how will future shutdowns of this nature be prevented;
(5) what actions have been undertaken to assist existing clients to find alternative sources of products normally produced at Pelindaba, particularly Technetium-99 generators for use in the field of nuclear medicine?